NEWS CENTER
SCROLL
May 15, 2023
15/ 05
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
Mar 23, 2023
23/ 03
Rona Therapeutics Announces Expansion of Scientific Advisory Board Newly Appointed Members include Tony W. Ho, M.D., and Aaron D. Gitler, Ph.D.
Jan 12, 2023
12/ 01
EnnovaBio Pharmaceuticals and Rona Therapeutics Announce Collaboration to Discover First-in-class siRNA Therapeutics to Treat Liver Diseases
Jul 25, 2022
25/ 07
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform
Apr 07, 2022
07/ 04
Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics
EXPLORER MORE
Jinyu Huang, Ph.D.
Chief Executive Officer, Founder
Stella Shi is founder, Chief Executive Officer and chairs the board of Rona Therapeutics since company inception in 2021 bringing ~15 years of biopharmaceutical industry and venture capital experience. Prior to founding Rona Therapeutics, Stella was managing director in Lilly Asia Ventures (LAV) from 2015 with proven track records with various venture creation ...